A study led by researchers at Alife Health, a fertility technology company building artificial intelligence (AI) tools designed to improve in-vitro fertilization (IVF) outcomes, found that an interpretable machine learning model can help doctors optimize ovulation trigger injection timing to improve patient outcomes for a significant number of patients. When undergoing IVF, patients are prescribed fertility medications to stimulate the ovaries to…
Male fertility startup Legacy has raised $25M in Series B funding led by Bain Capital Ventures. Other participants in the round include existing investors FirstMark Capital, Section 32 and TQ Ventures, as well as new investor Valor Equity Partners. This financing brings the company’s total funding to $45M. Legacy was founded in 2018 by Khaled Kteily with the goal to demystify male…
Menopause brand Womaness has announced a new partnership with Ulta Beauty, the largest beauty retailer in the U.S. Starting today, Womaness will be sold in select Ulta Beauty stores and online. The partnership signals an important moment in retail by providing access and visibility to items that cater specifically to the needs of the 40+ woman – an often overlooked segment. Womaness…
A couple of weeks ago Hertility took over London with its thought-provoking out-of-home campaign, but the company’s ambitions clearly aren’t limited to the UK. Today, as Hertility gears up for rapid international expansion, the company is announcing the acquisition of Netherlands-based competitor Grip. Until now, comprehensive data on women’s health hasn’t existed, but acquiring Grip will expand Hertility’s own dataset and help…
GE Healthcare has entered into an agreement to invest up to $50 million in Israeli startup Pulsenmore, marking another strategic step forward in enabling precision health. This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion. In addition to its equity investment, GE Healthcare will…
We last spoke about Celmatix in January, when the company announced that a novel PCOS target identified as part of its five-year, multi-target alliance with Evotec has progressed into hit-identification. Now the company is back with more promising news and this time it’s about premature menopause. According to a release Celmatix has identified of a novel AMHR2 agonist compound that has demonstrated…
A few years ago Eva Yazhari, General Partner at Beyond Capital Ventures (BCV) witnessed how a close relative passed away during childbirth in Tanzania. The experience stuck with her and in 2021, backed by an 11-year track record in investing, she announced the closing of BCV’s Fund I. BCV’s mission is to bring change to East Africa and India, where 1 billion…
It’s been a while since we spoke to Lorals Founder Melanie Cristol about the beginnings of Lorals and her journey to reinvent the dental dam. Back then in January 2021 she shared: “I originally envisioned Lorals as a dental dam replacement, after needing one during a romantic vacation—and feeling so stigmatized that it was the go-to product for us. It’s hard to find dental dams…
